Smith Brian J

Avg. Two Year Performance

25% Avg. Purchase Return
12% Compound
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(20%)(16%)7%25%
Purchase Success Rate2 of 31 of 32 of 33 of 33 of 3
Average Sale Return(2%)(32%)(1%)< 1%10%
Sale Success Rate1 of 30 of 31 of 31 of 31 of 3

Hospira Inc.

Drugs » Drug Delivery

SVP and Special Counsel:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--